10x Genomics, Inc. (NASDAQ:TXG) Director Mathai Mammen Sells 33,000 Shares

10x Genomics, Inc. (NASDAQ:TXG – Get Rating) Director Mathai Mammen sold 33,000 shares of the stock in a transaction on Thursday, May 11th. The stock was sold at an average price of $52.82, for a total value of $1,743,060.00. Following the transaction, the director now owns 169,745 shares of the company’s stock, valued at $8,965,930.90. […]

Related Keywords

United States ,China ,America ,Asia Pacific ,Mathai Mammen ,Stifel Nicolaus ,Blackrock Inc ,Nasdaq ,Genomics Inc ,Us Bancorp ,Financial Services Group Inc ,Raymond James Associates ,Genomics Company Profile ,Metlife Investment Management ,Barclays ,Morgan Stanley ,Get Rating ,Director Mathai Mammen ,Genomics Price ,Services Group ,Life Investment Management ,Genomics Company ,North America ,Middle East ,Genomics Daily ,10x Genomics ,Nasdaq Txg ,Ftxg ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,